MicroPort CardioFlow Medtech Corporation
HKEX:2160.HK
0.68 (HKD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 79.887 | 79.887 | 88.221 | 88.221 | 63.122 | 63.122 | 62.391 | 62.391 | 57.31 | 57.31 | 43.097 | 43.097 | 32.538 | 32.538 | 19.43 | 19.43 |
| Cost of Revenue
| 23.233 | 23.233 | 29.91 | 29.91 | 21.779 | 21.779 | 22.67 | 22.67 | 21.715 | 21.715 | 19.341 | 19.341 | 18.416 | 18.416 | 10.862 | 10.862 |
| Gross Profit
| 56.654 | 56.654 | 58.312 | 58.312 | 41.344 | 41.344 | 39.722 | 39.722 | 35.595 | 35.595 | 23.756 | 23.756 | 14.122 | 14.122 | 8.568 | 8.568 |
| Gross Profit Ratio
| 0.709 | 0.709 | 0.661 | 0.661 | 0.655 | 0.655 | 0.637 | 0.637 | 0.621 | 0.621 | 0.551 | 0.551 | 0.434 | 0.434 | 0.441 | 0.441 |
| Reseach & Development Expenses
| 63.924 | 63.924 | 54.747 | 54.747 | 72.087 | 72.087 | 39.805 | 39.805 | 51.067 | 51.067 | 24.499 | 24.499 | 33.258 | 33.258 | 15.162 | 15.162 |
| General & Administrative Expenses
| 20.851 | 20.851 | 14.259 | 14.259 | 19.026 | 19.026 | 16.97 | 16.97 | 10.735 | 10.735 | 6.942 | 6.942 | 12.28 | 12.28 | 10.33 | 10.33 |
| Selling & Marketing Expenses
| 68.097 | 68.097 | 43.407 | 43.407 | 49.864 | 49.864 | 30.524 | 30.524 | 38.47 | 38.47 | 19.738 | 19.738 | 16.654 | 16.654 | 9.025 | 9.025 |
| SG&A
| 88.948 | 88.948 | 57.665 | 57.665 | 68.89 | 68.89 | 47.494 | 47.494 | 49.205 | 49.205 | 26.68 | 26.68 | 28.934 | 28.934 | 19.355 | 19.355 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 221.853 | 221.853 | 166.218 | 166.218 | 218.909 | 218.909 | 104.533 | 104.533 | 96.895 | 96.895 | 56.317 | 56.317 | 108.014 | 108.014 | 43.257 | 43.257 |
| Operating Income
| -111.46 | -111.46 | -89.461 | -89.461 | -125.995 | -125.995 | -56.924 | -56.924 | -59.562 | -59.562 | -30.346 | -30.346 | -99.685 | -99.685 | -25.374 | -25.374 |
| Operating Income Ratio
| -1.395 | -1.395 | -1.014 | -1.014 | -1.996 | -1.996 | -0.912 | -0.912 | -1.039 | -1.039 | -0.704 | -0.704 | -3.064 | -3.064 | -1.306 | -1.306 |
| Total Other Income Expenses Net
| -32.517 | -32.517 | 1.646 | 1.646 | -38.876 | -38.876 | -3.855 | -3.855 | 3.02 | 3.02 | -4.438 | -4.438 | -38.461 | -38.461 | -35.525 | -35.525 |
| Income Before Tax
| -143.977 | -143.977 | -87.815 | -87.815 | -164.871 | -164.871 | -60.779 | -60.779 | -56.543 | -56.543 | -34.783 | -34.783 | -138.146 | -138.146 | -60.898 | -60.898 |
| Income Before Tax Ratio
| -1.802 | -1.802 | -0.995 | -0.995 | -2.612 | -2.612 | -0.974 | -0.974 | -0.987 | -0.987 | -0.807 | -0.807 | -4.246 | -4.246 | -3.134 | -3.134 |
| Income Tax Expense
| 2.09 | 2.09 | 1.887 | 1.887 | 1.137 | 1.137 | 0.411 | 0.411 | 0.057 | 0.057 | 0.25 | 0.25 | 0 | 0 | 0 | 0 |
| Net Income
| -146.066 | -146.066 | -89.701 | -89.701 | -166.008 | -166.008 | -61.19 | -61.19 | -56.6 | -56.6 | -35.033 | -35.033 | -138.146 | -138.146 | -60.898 | -60.898 |
| Net Income Ratio
| -1.828 | -1.828 | -1.017 | -1.017 | -2.63 | -2.63 | -0.981 | -0.981 | -0.988 | -0.988 | -0.813 | -0.813 | -4.246 | -4.246 | -3.134 | -3.134 |
| EPS
| -0.062 | -0.062 | -0.038 | -0.038 | -0.07 | -0.07 | -0.026 | -0.026 | -0.024 | -0.024 | -0.016 | -0.016 | -0.082 | -0.082 | -0.035 | -0.035 |
| EPS Diluted
| -0.062 | -0.062 | -0.038 | -0.038 | -0.07 | -0.07 | -0.026 | -0.026 | -0.024 | -0.024 | -0.016 | -0.016 | -0.082 | -0.082 | -0.035 | -0.035 |
| EBITDA
| -110.242 | -110.242 | -78.404 | -78.404 | -121.513 | -119.766 | -47.201 | -47.201 | -58.106 | -56.888 | -25.236 | -25.236 | -98.897 | -99.557 | -25.246 | -25.246 |
| EBITDA Ratio
| -1.38 | -1.38 | -0.889 | -0.889 | -1.925 | -1.897 | -0.757 | -0.757 | -1.014 | -0.993 | -0.586 | -0.586 | -3.039 | -3.06 | -1.299 | -1.299 |